| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2010 | EP1940353B1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 11/24/2010 | EP1934216B1 Naphthyridin derivatives |
| 11/24/2010 | EP1932525B1 Skin-care preparations containing mupirocin and betamethasone dipropionate |
| 11/24/2010 | EP1913400B1 Il-32 modulators |
| 11/24/2010 | EP1910398B1 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 11/24/2010 | EP1901734B1 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 11/24/2010 | EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 11/24/2010 | EP1896430B1 The preparation and use of compounds as aspartyl protease inhibitors |
| 11/24/2010 | EP1891006B1 Inhibitors of cytosolic phospholipase a2 |
| 11/24/2010 | EP1883451B1 Substituted indole compounds having nos inhibitory activity |
| 11/24/2010 | EP1865971B1 Lubricating composition |
| 11/24/2010 | EP1830836B1 Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller |
| 11/24/2010 | EP1785137B1 Remedy for hyperlipemia |
| 11/24/2010 | EP1758588B1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 11/24/2010 | EP1714653B1 Aqueous solution preparation containing a camptothecin |
| 11/24/2010 | EP1667719B1 Treatment of gastrointestinal stromal tumors with imatinib and midostaurin |
| 11/24/2010 | EP1641462B1 Enteric coated composition comprising prostaglandin analogs as chloride channel opener |
| 11/24/2010 | EP1615897B1 Pyrimidinone compounds as calcilytics |
| 11/24/2010 | EP1603917B1 Immunomodulating heterocyclic compounds |
| 11/24/2010 | EP1599493B1 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 11/24/2010 | EP1599466B1 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders |
| 11/24/2010 | EP1562585B1 Daily melatonin dosing units |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1545621B1 Pharmaceutical compositions comprising complexes of phosphate derivatives of lipophilic compounds |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1509494B1 Amidoacetonitrile compounds against parasites |
| 11/24/2010 | EP1501829B1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 11/24/2010 | EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1496742B1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 11/24/2010 | EP1474387B1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
| 11/24/2010 | EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/24/2010 | EP1429819B1 Optimized dosing for paclitaxel coated stents |
| 11/24/2010 | EP1407784B1 Antitumor agents |
| 11/24/2010 | EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 11/24/2010 | EP1381375B1 Oligonucleotide compositions and their use to induce differentiation of cells |
| 11/24/2010 | EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 11/24/2010 | EP1280764B1 Inhibitors of histone deacetylase |
| 11/24/2010 | EP1100454B1 Pharmaceutical compositions for managing skin conditions |
| 11/24/2010 | EP1075186B1 Method of hsv prophylaxis |
| 11/24/2010 | EP0891186B1 Nasal administration of agents for treatment of delayed onset emesis |
| 11/24/2010 | CN201642563U Hot pad for phlebitis |
| 11/24/2010 | CN1997367B Composition for the prevention and treatment of allergic inflammatory disease |
| 11/24/2010 | CN1985848B Compound vitamin and mineral preparation for prenatal taking |
| 11/24/2010 | CN1955159B Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use |
| 11/24/2010 | CN1951932B [N-(3',4'methylenedioxy)phenylethyl] formamidobenzoic acid derivative, its preparation method and uses |
| 11/24/2010 | CN1948248B Wheat bran total alkyl phenol extract and its preparation method and application |
| 11/24/2010 | CN1947796B Chemical modified adefovir and tynofovir |
| 11/24/2010 | CN1942181B Tablet containing branched chain amino acid and process for producing the same |
| 11/24/2010 | CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
| 11/24/2010 | CN1917775B Feed additive for laying hens and feed containing the additive |
| 11/24/2010 | CN1913900B Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 11/24/2010 | CN1897937B 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 11/24/2010 | CN1889922B Use of osteopontin in dental formulations |
| 11/24/2010 | CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 11/24/2010 | CN1861087B High purity wild Radix scutellariae glucoside medicine composition, and application of making medicine to treat diseases of cardiovascular and cerebrovascular |
| 11/24/2010 | CN1860371B Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases |
| 11/24/2010 | CN1747738B Sustained release of antifectives |
| 11/24/2010 | CN1578660B Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 11/24/2010 | CN101896595A Bactericidal cleanser composition |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896497A Antiviral agents |
| 11/24/2010 | CN101896490A Trisubstituted piperidines as renin inhibitors |
| 11/24/2010 | CN101896482A Novel thiophene derivatives as S1P1/EDG1 agonist |
| 11/24/2010 | CN101896481A Pyrimidyl indoline compound |
| 11/24/2010 | CN101896480A Tetrazole derivatives as modulators of metabotropic glutamate receptors (MGLURS) |
| 11/24/2010 | CN101896473A Inhibitors of stearoyl-coa desaturase |
| 11/24/2010 | CN101896472A HEDGEHOG pathway antagonists and therapeutic applications thereof |
| 11/24/2010 | CN101896471A Fluoroalkyl substituted benzimidazole cannabinoid agonists |
| 11/24/2010 | CN101896470A Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 11/24/2010 | CN101896469A Substituted hydantoins as MEK kinase inhibitors |
| 11/24/2010 | CN101896465A Cannabinoid receptor modulators |
| 11/24/2010 | CN101896464A Sinomenine derivatives and processes for their synthesis |
| 11/24/2010 | CN101896461A Gamma secretase modulators |
| 11/24/2010 | CN101896459A Anthelmintic agents and their use |
| 11/24/2010 | CN101896456A Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree |
| 11/24/2010 | CN101896455A 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 11/24/2010 | CN101896452A Carbon linked modulators of gamma-secretase |
| 11/24/2010 | CN101896227A Combination comprising an MEK inhibitor and an aurora kinase inhibitor |
| 11/24/2010 | CN101896210A Zibotentan composition containing mannitol and/or microcrystalline cellulose |
| 11/24/2010 | CN101896205A Compositions and methods employing NMDA antagonists for achieving an anesthetic-sparing effect |
| 11/24/2010 | CN101896204A Compositions and methods for treating purpura |
| 11/24/2010 | CN101896203A Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 11/24/2010 | CN101896199A Pharmaceutical formulation comprising hepatitis B virus neutralizing human antibody |
| 11/24/2010 | CN101896193A An agent for reducing a side effect of an anticancer drug |
| 11/24/2010 | CN101896189A Compositon for enhancing immunity |
| 11/24/2010 | CN101896186A Means and methods for counteracting muscle disorders |
| 11/24/2010 | CN101896185A Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 11/24/2010 | CN101896184A Inhibitors of anti-apoptotic proteins |
| 11/24/2010 | CN101896183A Bicyclic amides for enhancing glutamatergic synaptic responses |
| 11/24/2010 | CN101896182A Compostions and methods for using aminopyridines |
| 11/24/2010 | CN101896181A Use of ranolazine for elevated brain-type natriuretic peptide |
| 11/24/2010 | CN101896180A Combination 059 |
| 11/24/2010 | CN101896179A Tape preparation comprising etodolac in ionic liquid form |
| 11/24/2010 | CN101896178A Heterocyclic compounds as CRTH2 receptor antagonists |
| 11/24/2010 | CN101896177A Combinations of therapeutic agents for treating cancer |
| 11/24/2010 | CN101896176A Formulation to improve gastrointestinal function |
| 11/24/2010 | CN101896175A Loxoprofen-containing aqueous plaster |
| 11/24/2010 | CN101896174A Trans-clomiphene for metabolic syndrome |
| 11/24/2010 | CN101896167A Pharmaceutical compositions |